Liu, L. Y., Strassner, J. P., Refat, M. A., Harris, J. E., & King, B. A. (2017). Repigmentation in vitiligo using the janus kinase inhibitor, tofacitinib, may require concomitant light exposure. J Am Acad Dermatol.

Liu, Lucy Y., James P. Strassner, Maggi A. Refat, John E. Harris, und Brett A. King. "Repigmentation in Vitiligo Using the Janus Kinase Inhibitor, Tofacitinib, May Require Concomitant Light Exposure." J Am Acad Dermatol 2017.

Liu, Lucy Y., et al. "Repigmentation in Vitiligo Using the Janus Kinase Inhibitor, Tofacitinib, May Require Concomitant Light Exposure." J Am Acad Dermatol 2017.